State Street Corp 180 Life Sciences Corp. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$2.53 - $3.9 $22,924 - $35,337
9,061 Added 14.04%
73,587 $191,000
Q4 2021

Feb 14, 2022
BUY
$3.27 - $6.38 $45,780 - $89,320
14,000 Added 27.71%
64,526 $252,000
Q3 2021

Nov 15, 2021
SELL
$5.11 - $10.81 $65,919 - $139,449
-12,900 Reduced 20.34%
50,526 $273,000
Q2 2021

Aug 16, 2021
BUY
$6.7 - $11.98 $424,954 - $759,843
63,426 New
63,426 $634,000

About 180 Life Sciences Corp.

ATNF Quotes by TradingView
  • Ticker ATNF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,698,900
  • Market Cap $81.1M
  • Description
  • 1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on f...
More about ATNF
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email